(Q44815926)

6 December 2017

title

Antifungal treatment of Candida peritonitis in continuous ambulatory peritoneal dialysis patients (English)

1 reference

6 December 2017

0 references

1 reference

Struijk DG

1

1 reference

6 December 2017

Krediet RT

2

1 reference

6 December 2017

Boeschoten EW

3

1 reference

6 December 2017

Rietra PJ

4

1 reference

6 December 2017

Arisz L

5

1 reference

6 December 2017

publication date

1 January 1987

1 reference

American Journal of Kidney Diseases

6 December 2017

published in

1 reference

6 December 2017

volume

9

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

66-70

1 reference

Fungal Peritonitis in Patients on Continuous Ambulatory Peritoneal Dialysis

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Successful in situ treatment of a fungal peritonitis during CAPD

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Chemotherapy and/or removal of the peritoneal catheter in the management of fungal peritonitis complicating CAPD?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Flucytosine-miconazole treatment of Candida peritonitis. Its use during continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Peritonitis during continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

CAPD peritonitis: a prospective randomized trial of oral versus intraperitoneal treatment with cephradine.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Tablet sensitivity testing on pathogenic fungi

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Candida peritonitis complicating chronic peritoneal dialysis: a report of five cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Indwelling peritoneal (Tenckhoff) dialysis catheter. Experience with 24 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Uncommon causes of peritonitis in patients undergoing peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Synergism of Amphotericin B and 5-Fluorocytosine for Candida Species

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

1 reference

7 January 2021

Acetate versus lactate in peritoneal dialysis solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Three recoveries in 5 cases without catheter removal.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980164-6

7 January 2021

10.1016/S0272-6386(87)80164-6

Identifiers

DOI

1 reference

6 December 2017

1 reference